| Randomized trial of platelet-transfusion thresholds in neonates A Curley, SJ Stanworth, K Willoughby, SF Fustolo-Gunnink, V Venkatesh, ... New England Journal of Medicine 380 (3), 242-251, 2019 | 403 | 2019 |
| Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans A Borchiellini, K Fijnvandraat, JW ten Cate, D Pajkrt, SJ Van Deventer, ... | 296 | 1996 |
| Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A CL Eckhardt, AS Van Velzen, M Peters, J Astermark, PP Brons, ... Blood, The Journal of the American Society of Hematology 122 (11), 1954-1962, 2013 | 273 | 2013 |
| Factor VIII inhibitors in mild and moderate-severity haemophilia A CRM Hay, CA Ludlam, BT Colvin, FGH Hill, FE Preston, N Wasseem, ... Thrombosis and haemostasis 79 (04), 762-766, 1998 | 266 | 1998 |
| von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation JA van Mourik, R Boertjes, IA Huisveld, K Fijnvandraat, D Pajkrt, ... Blood, The Journal of the American Society of Hematology 94 (1), 179-185, 1999 | 265 | 1999 |
| The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trial J Howard, M Malfroy, C Llewelyn, L Choo, R Hodge, T Johnson, S Purohit, ... The Lancet 381 (9870), 930-938, 2013 | 263 | 2013 |
| Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality K Fijnvandraat, B Derkx, M Peters, R Bijlmer, A Sturk, MH Prins, ... Thrombosis and haemostasis 73 (01), 015-020, 1995 | 243 | 1995 |
| Non‐genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report J Astermark, C Altisent, A Batorova, MJ Diniz, A Gringeri, PA Holme, ... Haemophilia 16 (5), 747-766, 2010 | 186 | 2010 |
| Endothelial protein C receptor CT Esmon, J Xu, J Gu, D Qu, Z Laszik, G Ferrell, DJ Stearns-Kurosawa, ... Thrombosis and haemostasis 82 (08), 251-258, 1999 | 183 | 1999 |
| Thrombocytopenia in neonatal sepsis: Incidence, severity and risk factors IMC Ree, SF Fustolo-Gunnink, V Bekker, KJ Fijnvandraat, SJ Steggerda, ... PloS one 12 (10), e0185581, 2017 | 146 | 2017 |
| Diagnosis and management of haemophilia K Fijnvandraat, MH Cnossen, FWG Leebeek, M Peters Bmj 344, 2012 | 142 | 2012 |
| Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease EM de Wee, YV Sanders, EP Mauser-Bunschoten, JG van der Bom, ... Thrombosis and haemostasis 108 (10), 683-692, 2012 | 137 | 2012 |
| Inter‐individual variation in half‐life of infused recombinant factor VIII is related to pre‐infusion von Willebrand factor antigen levels K Fijnvandraat, M Peters, JW Ten Cate British journal of haematology 91 (2), 474-476, 1995 | 135 | 1995 |
| Intensive peri-operative use of factor VIII and the Arg593→ Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A CL Eckhardt, LA Menke, CH Van Ommen, JH Van der Lee, RB Geskus, ... Journal of Thrombosis and haemostasis 7 (6), 930-937, 2009 | 133 | 2009 |
| Growth and nutritional status of children with homozygous sickle cell disease AWM Al-Saqladi, R Cipolotti, K Fijnvandraat, BJ Brabin Annals of tropical paediatrics 28 (3), 165-189, 2008 | 130 | 2008 |
| von Willebrand disease and aging: an evolving phenotype YV Sanders, MA Giezenaar, BAP Laros‐van Gorkom, K Meijer, ... Journal of Thrombosis and Haemostasis 12 (7), 1066-1075, 2014 | 129 | 2014 |
| Neurocognitive deficits in children with sickle cell disease: a comprehensive profile CT Hijmans, K Fijnvandraat, MA Grootenhuis, N van Geloven, H Heijboer, ... Pediatric blood & cancer 56 (5), 783-788, 2011 | 127 | 2011 |
| Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients K Fijnvandraat, E Berntorp, JW Ten Cate, H Johnsson, M Peters, ... Thrombosis and haemostasis 77 (02), 298-302, 1997 | 121 | 1997 |
| Health‐related quality of life among adult patients with moderate and severe von Willebrand disease EM de Wee, EP MAUSER‐BUNSCHOTEN, JG van der Bom, ... Journal of Thrombosis and Haemostasis 8 (7), 1492-1499, 2010 | 120 | 2010 |
| Reduced prevalence of arterial thrombosis in von Willebrand disease YV Sanders, J Eikenboom, EM de Wee, JG van der Bom, MH Cnossen, ... Journal of Thrombosis and Haemostasis 11 (5), 845-854, 2013 | 119 | 2013 |
